Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPLP2P1 is a processed pseudogene, which means it is a genomic DNA sequence similar to the functional gene (RPLP2) but generally does not produce a functional protein product. It has no known biological role or direct disease association and is not considered a therapeutic target. Multiple processed pseudogenes exist in the genome for ribosomal protein genes such as RPLP2. The RPLP2 gene (not the pseudogene), encodes the ribosomal protein lateral stalk subunit P2, a component of the large 60S ribosomal subunit important for protein synthesis. However, RPLP2P1 does not encode a functional protein. Its mention in databases is for genomic annotation purposes. The gene is consistently annotated as pseudogene in appropriate genomic databases. It is not a receptor, enzyme, transporter, or recognized drug target. There is nothing to suggest a role in cell biology or pathology directly attributable to RPLP2P1. Thus, marking as is_target: false and is_incorrect: true is appropriate for any biomedical or therapeutic target effort.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein lateral stalk subunit P2 pseudogene 1 (RPLP2P1).